Survey of stress ulcer prophylaxis

Brian L Erstad, Jeffrey F. Barletta, Judith Jacobi, Aaron D. Killian, Katherine M. Kramer, Steven J. Martin

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Background: No surveys of stress ulcer prophylaxis prescribing in the USA have been conducted since 1995. Since that time, the most comprehensive meta-analysis and largest randomized study to date concerning stress ulcer prophylaxis have been published. Results: Three hundred sixty-eight surveys were sent to all members of the Section of Pharmacy and Pharmacology of the Society of Critical Care Medicine. One hundred fifty-three (42%) surveys were returned. Representatives from 86% of institutions stated that medications for stress ulcer prophylaxis are used in a majority (>90%) of patients admitted to the intensive care unit (ICU). Twenty-two per cent of institutions have recommendations for both ICU and non-ICU settings. Fifty- eight per cent of institutions stated that there was one preferred medication for stress ulcer prophylaxis, and in 77% of these histamine-2-antagonists were the most popular. Conclusions: There are wide variations in prescribing practices for stress ulcer prophylaxis. Institutions should consult published literature and use pre-existing guidelines as templates for developing their own guidelines.

Original languageEnglish (US)
Pages (from-to)145-149
Number of pages5
JournalCritical Care
Volume3
Issue number6
DOIs
StatePublished - 1999

Fingerprint

Ulcer
Intensive Care Units
Guidelines
Histamine Antagonists
Meta-Analysis
Surveys and Questionnaires
Pharmacology

Keywords

  • Medications
  • Prophylaxis
  • Stress ulcers
  • Survey

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Cite this

Erstad, B. L., Barletta, J. F., Jacobi, J., Killian, A. D., Kramer, K. M., & Martin, S. J. (1999). Survey of stress ulcer prophylaxis. Critical Care, 3(6), 145-149. https://doi.org/10.1186/cc368

Survey of stress ulcer prophylaxis. / Erstad, Brian L; Barletta, Jeffrey F.; Jacobi, Judith; Killian, Aaron D.; Kramer, Katherine M.; Martin, Steven J.

In: Critical Care, Vol. 3, No. 6, 1999, p. 145-149.

Research output: Contribution to journalArticle

Erstad, BL, Barletta, JF, Jacobi, J, Killian, AD, Kramer, KM & Martin, SJ 1999, 'Survey of stress ulcer prophylaxis', Critical Care, vol. 3, no. 6, pp. 145-149. https://doi.org/10.1186/cc368
Erstad BL, Barletta JF, Jacobi J, Killian AD, Kramer KM, Martin SJ. Survey of stress ulcer prophylaxis. Critical Care. 1999;3(6):145-149. https://doi.org/10.1186/cc368
Erstad, Brian L ; Barletta, Jeffrey F. ; Jacobi, Judith ; Killian, Aaron D. ; Kramer, Katherine M. ; Martin, Steven J. / Survey of stress ulcer prophylaxis. In: Critical Care. 1999 ; Vol. 3, No. 6. pp. 145-149.
@article{498c947c14f440279b40f0fd36786da5,
title = "Survey of stress ulcer prophylaxis",
abstract = "Background: No surveys of stress ulcer prophylaxis prescribing in the USA have been conducted since 1995. Since that time, the most comprehensive meta-analysis and largest randomized study to date concerning stress ulcer prophylaxis have been published. Results: Three hundred sixty-eight surveys were sent to all members of the Section of Pharmacy and Pharmacology of the Society of Critical Care Medicine. One hundred fifty-three (42{\%}) surveys were returned. Representatives from 86{\%} of institutions stated that medications for stress ulcer prophylaxis are used in a majority (>90{\%}) of patients admitted to the intensive care unit (ICU). Twenty-two per cent of institutions have recommendations for both ICU and non-ICU settings. Fifty- eight per cent of institutions stated that there was one preferred medication for stress ulcer prophylaxis, and in 77{\%} of these histamine-2-antagonists were the most popular. Conclusions: There are wide variations in prescribing practices for stress ulcer prophylaxis. Institutions should consult published literature and use pre-existing guidelines as templates for developing their own guidelines.",
keywords = "Medications, Prophylaxis, Stress ulcers, Survey",
author = "Erstad, {Brian L} and Barletta, {Jeffrey F.} and Judith Jacobi and Killian, {Aaron D.} and Kramer, {Katherine M.} and Martin, {Steven J.}",
year = "1999",
doi = "10.1186/cc368",
language = "English (US)",
volume = "3",
pages = "145--149",
journal = "Critical Care",
issn = "1364-8535",
publisher = "BioMed Central Ltd.",
number = "6",

}

TY - JOUR

T1 - Survey of stress ulcer prophylaxis

AU - Erstad, Brian L

AU - Barletta, Jeffrey F.

AU - Jacobi, Judith

AU - Killian, Aaron D.

AU - Kramer, Katherine M.

AU - Martin, Steven J.

PY - 1999

Y1 - 1999

N2 - Background: No surveys of stress ulcer prophylaxis prescribing in the USA have been conducted since 1995. Since that time, the most comprehensive meta-analysis and largest randomized study to date concerning stress ulcer prophylaxis have been published. Results: Three hundred sixty-eight surveys were sent to all members of the Section of Pharmacy and Pharmacology of the Society of Critical Care Medicine. One hundred fifty-three (42%) surveys were returned. Representatives from 86% of institutions stated that medications for stress ulcer prophylaxis are used in a majority (>90%) of patients admitted to the intensive care unit (ICU). Twenty-two per cent of institutions have recommendations for both ICU and non-ICU settings. Fifty- eight per cent of institutions stated that there was one preferred medication for stress ulcer prophylaxis, and in 77% of these histamine-2-antagonists were the most popular. Conclusions: There are wide variations in prescribing practices for stress ulcer prophylaxis. Institutions should consult published literature and use pre-existing guidelines as templates for developing their own guidelines.

AB - Background: No surveys of stress ulcer prophylaxis prescribing in the USA have been conducted since 1995. Since that time, the most comprehensive meta-analysis and largest randomized study to date concerning stress ulcer prophylaxis have been published. Results: Three hundred sixty-eight surveys were sent to all members of the Section of Pharmacy and Pharmacology of the Society of Critical Care Medicine. One hundred fifty-three (42%) surveys were returned. Representatives from 86% of institutions stated that medications for stress ulcer prophylaxis are used in a majority (>90%) of patients admitted to the intensive care unit (ICU). Twenty-two per cent of institutions have recommendations for both ICU and non-ICU settings. Fifty- eight per cent of institutions stated that there was one preferred medication for stress ulcer prophylaxis, and in 77% of these histamine-2-antagonists were the most popular. Conclusions: There are wide variations in prescribing practices for stress ulcer prophylaxis. Institutions should consult published literature and use pre-existing guidelines as templates for developing their own guidelines.

KW - Medications

KW - Prophylaxis

KW - Stress ulcers

KW - Survey

UR - http://www.scopus.com/inward/record.url?scp=0033404629&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033404629&partnerID=8YFLogxK

U2 - 10.1186/cc368

DO - 10.1186/cc368

M3 - Article

VL - 3

SP - 145

EP - 149

JO - Critical Care

JF - Critical Care

SN - 1364-8535

IS - 6

ER -